Back to search

Peptide record

TPDB06796

Antibacterial Anticancer Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06796
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 12-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
VQRWLIVWRIRK
Physicochemical Analysis
C79H129N25O14
ANDCEGHMFPSTY
R
1653.05
12.71
4
0
7
+4
-0.74
-0.125
145.83
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
11000
665.44
1
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
1
Q
0
G
0
H
2
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
2
W
0
Y
2
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 2 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 2
Chemical Descriptors
12
C79H129N25O14
1653.05
12.71
+4
-0.74
-0.125
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human monocytes

Target

Human monocytes

Source & Reference

NA
DBAASP
Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models. | PLoS One | 2013
Evidence 2 Activity

Activity

0% Killing
Toxicity
32 µg/mL
Cytotoxic
0% Killing | 32 | µg/mL | target cell: Mouse fibroblasts L929

Target

Mouse fibroblasts L929

Source & Reference

NA
DBAASP
Host defense peptide IDR-1002 associated with ciprofloxacin as a new antimicrobial and immunomodulatory strategy for dental pulp revascularization therapy. | Microb Pathog | 2020